1
|
Arnaud J, Weykamp C, Wenzel R, Patriarca M, González-Estecha M, Janssen L, Fofou-Caillierez MB, Alemany MV, Patriarca V, de Graaf I, Persoons R, Panadès M, China B, Winkel MT, van der Vuurst H, Thelen M. Analytical performance specifications for trace elements in biological fluids derived from six countries federated external quality assessment schemes over 10 years. Clin Chem Lab Med 2024; 0:cclm-2024-0551. [PMID: 39027966 DOI: 10.1515/cclm-2024-0551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Accepted: 07/07/2024] [Indexed: 07/20/2024]
Abstract
OBJECTIVES This article defines analytical performance specifications (APS) for evaluating laboratory proficiency through an external quality assessment scheme. METHODS Standard deviations for proficiency assessment were derived from Thompson's characteristic function applied to robust data calculated from participants' submissions in the Occupational and Environmental Laboratory Medicine (OELM) external quality assurance scheme for trace elements in serum, whole blood and urine. Characteristic function was based on two parameters: (1) β - the average coefficient of variation (CV) at high sample concentrations; (2) α - the average standard deviation (SD) at low sample concentrations. APSs were defined as 1.65 standard deviations calculated by Thompson's approach. Comparison between OELM robust data and characteristic function were used to validate the model. RESULTS Application of the characteristic function allowed calculated APS for 18 elements across three matrices. Some limitations were noted, particularly for elements (1) with no sample concentrations near analytical technique limit of detection; (2) exhibiting high robust CV at high concentration; (3) exhibiting high analytical variability such as whole blood Tl and urine Pb; (4) with an unbalanced number of robust SD above and under the characteristic function such as whole blood Mn and serum Al and Zn. CONCLUSIONS The characteristic function was a useful means of deriving APS for trace elements in biological fluids where biological variation data or outcome studies were not available. However, OELM external quality assurance scheme data suggests that the characteristic functions are not appropriate for all elements.
Collapse
Affiliation(s)
- Josiane Arnaud
- Member of French Society for Clinical Biology (SFBC), and French Speaking Society for Trace Elements, Vitamins and Biofactors (SETViB), Paris, France
| | - Cas Weykamp
- MCA Laboratory, Queen Beatrix Hospital, Winterswijk, The Netherlands
| | - Ross Wenzel
- Pathology NSW, Royal North Shore Hospital, St Leonards, NSW, Australia
| | - Marina Patriarca
- Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy
| | | | - Liesbeth Janssen
- MCA Laboratory, Queen Beatrix Hospital, Winterswijk, The Netherlands
| | | | | | - Valeria Patriarca
- Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy
| | - Irene de Graaf
- MCA Laboratory, Queen Beatrix Hospital, Winterswijk, The Netherlands
| | - Renaud Persoons
- University of Grenoble Alpes, CNRS, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France
| | - Mariona Panadès
- External Quality Assessment Schemes, Spanish Society of Laboratory Medicine, Barcelona, Spain
| | - Bernard China
- Department of Quality of Laboratories, Sciensano, Brussels, Belgium
| | - Marieke Te Winkel
- MCA Laboratory, Queen Beatrix Hospital, Winterswijk, The Netherlands
| | | | - Marc Thelen
- Foundation of Quality Assurance in Laboratory Medicine (SKML), Nijmegen, The Netherlands
- Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
| |
Collapse
|
2
|
Oleko A, Saoudi A, Zeghnoun A, Pecheux M, Cirimele V, Mihai Cirtiu C, Berail G, Szego E, Denys S, Fillol C. Exposure of the general French population to metals and metalloids in 2014-2016: Results from the Esteban study. ENVIRONMENTAL RESEARCH 2024; 252:118744. [PMID: 38579993 DOI: 10.1016/j.envres.2024.118744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 03/13/2024] [Accepted: 03/16/2024] [Indexed: 04/07/2024]
Abstract
BACKGROUND The purpose of the Esteban study was to describe levels of various biomarkers of exposure to several environmental pollutants, including metals and metalloids, among the French population. This paper describes the distribution of concentrations of 28 metals and metalloids in two different populations, and estimates the main determinants of exposure to total arsenic, the sum of inorganic arsenic (iAs) and its two metabolites monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA), cadmium, chromium, copper, mercury and nickel. METHODS Esteban is a cross-sectional study conducted between 2014 and 2016 on a random sample of 2503 adults (18-74 years old) and 1104 children (6-17 years old) from the general population. The data collected included biological samples (blood, hair, and urines), socio-demographic characteristics, environmental and occupational exposure, and information on dietary factors and lifestyle. The geometric mean and percentiles of the distribution were estimated for each metal. Multivariate analyses were performed to identify the determinants of exposure using a generalized linear model. RESULTS Only four metals had a quantification rate below 90% in adults (beryllium, iridium, palladium, and platinum), and three metals in children (beryllium, iridium, and platinum). The concentrations of total arsenic, cadmium, chromium and mercury were higher than those found in most international studies. The determinants significantly associated with exposure were mainly diet and smoking. CONCLUSIONS Esteban provided a nationwide description of 28 metal and metalloid exposure levels for adults (some never measured before) and for the first time in children. The study results highlighted widespread exposure to several metals and metalloids. These results could be used to advocate public health decisions for continued efforts to reduce harmful exposure to toxic metals. The Reference values (RV95) built from Esteban could also be used to support future government strategies.
Collapse
Affiliation(s)
- Amivi Oleko
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France.
| | - Abdessattar Saoudi
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France
| | - Abdelkrim Zeghnoun
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France
| | - Marie Pecheux
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France
| | - Vincent Cirimele
- ChemTox 3 Rue Grüninger, Parc D'Innovation F, Illkirch Graffenstaden, 67400, France
| | - Ciprian Mihai Cirtiu
- Centre de Toxicologie Du Québec (CTQ), Institut National de Santé Publique Du Québec (INSPQ), 945 Av., Wolfe, Québec, G1V 5B3, Canada
| | - Géraldine Berail
- Laboratoire de l'Environnement et de l'Alimentation de la Vendée (LEA Vendée), La Roche sur Yon, France
| | - Emmanuelle Szego
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France
| | - Sébastien Denys
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France
| | - Clémence Fillol
- Santé Publique France, French Public Health Agency, 12 Rue Du Val D'Osne, 94415, Saint Maurice Cedex, France
| |
Collapse
|
3
|
Yang L, Yu Q, Dou S, Li X, Wen S, Zhang J, Feng M, Yan L, Zhang C, Li S, Lu P, Guo Y. Whole blood cadmium levels and depressive symptoms in Chinese young adults: A prospective cohort study combing metabolomics. JOURNAL OF HAZARDOUS MATERIALS 2024; 465:132968. [PMID: 38000288 DOI: 10.1016/j.jhazmat.2023.132968] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2023] [Revised: 10/25/2023] [Accepted: 11/07/2023] [Indexed: 11/26/2023]
Abstract
OBJECTIVES To investigate the association between Cd exposure and depressive symptoms in Chinese young adults. And to investigate the potential metabolic changes associated with high blood Cd concentrations. METHODS We conducted a cohort study in 2019 and 2021. Blood Cd and depressive symptoms were collected during baseline and follow-up. The nine-item Patient Health Questionnaire (PHQ-9) scores were used to assess depressive symptoms. We used the generalized linear mixed model to estimate the association between blood Cd levels and depressive symptoms. A metabolomic and lipidomic analysis based on liquid chromatography-mass spectrometry was conducted on a total of 679 blood samples. The metabolomic data were analyzed using variance analysis and linear mixed effects models. RESULTS Blood Cd concentrations were significantly associated with increased severity of depression symptoms [odds ratio (OR) 2.07, 95% confidence interval (CI) 1.04-4.11]. Metabolomics analysis found 93 metabolites with significant statistical differences between the lowest blood Cd level group and the highest Cd level group. Among the 93 differential metabolites, 17 were enriched in 7 differential metabolic pathways. CONCLUSIONS Blood Cd was associated with increased severity of depression symptoms in Chinese young adults. Cd exposure may affect depressive symptoms by inducing oxidative stress, inflammation, and disrupting amino acid metabolism.
Collapse
Affiliation(s)
- Liu Yang
- Binzhou Medical University, Yantai, Shandong, China
| | - Qingxia Yu
- Department of Critical Care Medicine, Yantai Yuhuangding Hospital, Yantai, Shandong, China
| | - Siqi Dou
- Binzhou Medical University, Yantai, Shandong, China
| | - Xinyuan Li
- Binzhou Medical University, Yantai, Shandong, China
| | - Shuo Wen
- Binzhou Medical University, Yantai, Shandong, China
| | - Jia Zhang
- Binzhou Medical University, Yantai, Shandong, China
| | - Mingyu Feng
- Binzhou Medical University, Yantai, Shandong, China
| | - Lailai Yan
- Department of Laboratory Science and Technology, School of Public Health, Peking University, Beijing, China
| | | | - Shanshan Li
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
| | - Peng Lu
- Binzhou Medical University, Yantai, Shandong, China.
| | - Yuming Guo
- Binzhou Medical University, Yantai, Shandong, China; Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
| |
Collapse
|
4
|
Fernández-Martínez NF, Rodríguez-Barranco M, Huerta JM, Gil F, Olmedo P, Molina-Montes E, Guevara M, Zamora-Ros R, Jiménez-Zabala A, Colorado-Yohar SM, Ardanaz E, Bonet C, Amiano P, Chirlaque MD, Pérez-Gómez B, Jiménez-Moleón JJ, Martín-Jiménez M, de Santiago E, Sánchez MJ. Breast cancer risk for the joint exposure to metals and metalloids in women: Results from the EPIC-Spain cohort. THE SCIENCE OF THE TOTAL ENVIRONMENT 2024; 912:168816. [PMID: 38036124 DOI: 10.1016/j.scitotenv.2023.168816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/17/2023] [Revised: 11/21/2023] [Accepted: 11/21/2023] [Indexed: 12/02/2023]
Abstract
Environmental factors play a role in breast cancer development. While metals and metalloids (MMs) include some carcinogens, their association with breast cancer depends on the element studied. Most studies focus on individual MMs, but the combined effects of metal mixtures remain unclear. The aim of this study was to analyze the relationship between the joint exposure to MMs and the risk of developing female breast cancer. We conducted a case-control study within the multicenter prospective EPIC-Spain cohort. Study population comprised 292 incident cases and 286 controls. Plasma concentrations of 16 MMs were quantified at recruitment. Potential confounders were collected using a questionnaire and anthropometric measurements. Mixed-effects logistic regression models were built to explore the effect of individual MMs. Quantile-based g computation models were applied to identify the main mixture components and to estimate the joint effect of the metal mixture. The geometric means were highest for Cu (845.6 ng/ml) and Zn (604.8 ng/ml). Cases had significantly higher Cu concentrations (p = 0.010) and significantly lower Zn concentrations (p < 0.001). Cu (+0.42) and Mn (+0.13) showed the highest positive weights, whereas Zn (-0.61) and W (-0.16) showed the highest negative weights. The joint effect of the metal mixture was estimated at an OR = 4.51 (95%CI = 2.32-8.79), suggesting a dose-response relationship. No evidence of non-linearity or non-additivity was found. An unfavorable exposure profile, primarily characterized by high Cu and low Zn levels, could lead to a significant increase in the risk of developing female breast cancer. Further studies are warranted to confirm these findings.
Collapse
Affiliation(s)
- Nicolás Francisco Fernández-Martínez
- Instituto de Investigación Biosanitaria ibs, GRANADA, 18012 Granada, Spain; Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain
| | - Miguel Rodríguez-Barranco
- Instituto de Investigación Biosanitaria ibs, GRANADA, 18012 Granada, Spain; Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.
| | - José María Huerta
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, 30008 Murcia, Spain
| | - Fernando Gil
- Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain
| | - Pablo Olmedo
- Department of Preventive Medicine and Public Health, University of Granada, 18071 Granada, Spain
| | - Esther Molina-Montes
- Instituto de Investigación Biosanitaria ibs, GRANADA, 18012 Granada, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Nutrition and Food Science, University of Granada, 18011 Granada, Spain; Institute of Nutrition and Food Technology (INYTA) 'Jose Mataix', Biomedical Research Center, University of Granada, 18071 Granada, Spain
| | - Marcela Guevara
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
| | - Raúl Zamora-Ros
- Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08908 Bellvitge, Spain; Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain
| | - Ana Jiménez-Zabala
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, 20013 San Sebastian, Spain; BioGipuzkoa Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, 20014 San Sebastián, Spain
| | - Sandra Milena Colorado-Yohar
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, 30008 Murcia, Spain; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia
| | - Eva Ardanaz
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Instituto de Salud Pública y Laboral de Navarra, 31003 Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
| | - Catalina Bonet
- Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO), 08908 Bellvitge, Spain; Biomedical Research Institute (IDIBELL), 08908 Barcelona, Spain
| | - Pilar Amiano
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, 20013 San Sebastian, Spain; BioGipuzkoa Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, 20014 San Sebastián, Spain
| | - María Dolores Chirlaque
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, 30008 Murcia, Spain
| | - Beatriz Pérez-Gómez
- Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Epidemiology for Chronic Diseases, National Center of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain
| | - José Juan Jiménez-Moleón
- Instituto de Investigación Biosanitaria ibs, GRANADA, 18012 Granada, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Legal Medicine and Toxicology, University of Granada, 18016 Granada, Spain
| | - Miguel Martín-Jiménez
- Hospital Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, 28007 Madrid, Spain; GEICAM, Spanish Breast Cancer Group, 28703 Madrid, Spain; Consorcio de Investigación Biomédica en Red de Oncología (CIBERONC), 28029 Madrid, Spain
| | - Esperanza de Santiago
- GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, 18016 Granada, Spain
| | - María-José Sánchez
- Instituto de Investigación Biosanitaria ibs, GRANADA, 18012 Granada, Spain; Escuela Andaluza de Salud Pública (EASP), 18011 Granada, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain; Department of Legal Medicine and Toxicology, University of Granada, 18016 Granada, Spain
| |
Collapse
|
5
|
Reale E, Zare Jeddi M, Paini A, Connolly A, Duca R, Cubadda F, Benfenati E, Bessems J, S Galea K, Dirven H, Santonen T, M Koch H, Jones K, Sams C, Viegas S, Kyriaki M, Campisi L, David A, Antignac JP, B Hopf N. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment. ENVIRONMENT INTERNATIONAL 2024; 184:108474. [PMID: 38350256 DOI: 10.1016/j.envint.2024.108474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 12/15/2023] [Accepted: 02/01/2024] [Indexed: 02/15/2024]
Abstract
Human health risk assessment is historically built upon animal testing, often following Organisation for Economic Co-operation and Development (OECD) test guidelines and exposure assessments. Using combinations of human relevant in vitro models, chemical analysis and computational (in silico) approaches bring advantages compared to animal studies. These include a greater focus on the human species and on molecular mechanisms and kinetics, identification of Adverse Outcome Pathways and downstream Key Events as well as the possibility of addressing susceptible populations and additional endpoints. Much of the advancement and progress made in the Next Generation Risk Assessment (NGRA) have been primarily focused on new approach methodologies (NAMs) and physiologically based kinetic (PBK) modelling without incorporating human biomonitoring (HBM). The integration of toxicokinetics (TK) and PBK modelling is an essential component of NGRA. PBK models are essential for describing in quantitative terms the TK processes with a focus on the effective dose at the expected target site. Furthermore, the need for PBK models is amplified by the increasing scientific and regulatory interest in aggregate and cumulative exposure as well as interactions of chemicals in mixtures. Since incorporating HBM data strengthens approaches and reduces uncertainties in risk assessment, here we elaborate on the integrated use of TK, PBK modelling and HBM in chemical risk assessment highlighting opportunities as well as challenges and limitations. Examples are provided where HBM and TK/PBK modelling can be used in both exposure assessment and hazard characterization shifting from external exposure and animal dose/response assays to animal-free, internal exposure-based NGRA.
Collapse
Affiliation(s)
- Elena Reale
- Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland
| | - Maryam Zare Jeddi
- National Institute for Public Health and the Environment (RIVM), the Netherlands
| | | | - Alison Connolly
- UCD Centre for Safety & Health at Work, School of Public Health, Physiotherapy, and Sports Science, University College Dublin, D04 V1W8, Dublin, Ireland for Climate and Air Pollution Studies, Physics, School of Natural Science and the Ryan Institute, National University of Ireland, University Road, Galway H91 CF50, Ireland
| | - Radu Duca
- Unit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, Laboratoire national de santé (LNS), 1, Rue Louis Rech, 3555 Dudelange, Luxembourg; Environment and Health, Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35, 3000 Leuven, Belgium
| | - Francesco Cubadda
- Istituto Superiore di Sanità - National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
| | - Emilio Benfenati
- Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milano, Italy
| | - Jos Bessems
- VITO HEALTH, Flemish Institute for Technological Research, 2400 Mol, Belgium
| | - Karen S Galea
- Institute of Occupational Medicine (IOM), Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK
| | - Hubert Dirven
- Department of Climate and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - Tiina Santonen
- Finnish Institute of Occupational Health (FIOH), P.O. Box 40, FI-00032 Työterveyslaitos, Finland
| | - Holger M Koch
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
| | - Kate Jones
- HSE - Health and Safety Executive, Harpur Hill, Buxton SK17 9JN, UK
| | - Craig Sams
- HSE - Health and Safety Executive, Harpur Hill, Buxton SK17 9JN, UK
| | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, Comprehensive Health Research Center, CHRC, NOVA University Lisbon, Lisbon, Portugal
| | - Machera Kyriaki
- Benaki Phytopathological Institute, 8, Stephanou Delta Street, 14561 Kifissia, Athens, Greece
| | - Luca Campisi
- Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy; Flashpoint srl, Via Norvegia 56, 56021 Cascina (PI), Italy
| | - Arthur David
- Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, F-35000 Rennes, France
| | | | - Nancy B Hopf
- Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland.
| |
Collapse
|
6
|
Sprong RC, van den Brand AD, van Donkersgoed G, Blaznik U, Christodoulou D, Crépet A, da Graça Dias M, Hamborg Jensen B, Morretto A, Rauscher-Gabernig E, Ruprich J, Sokolić D, van Klaveren JD, Luijten M, Mengelers MJB. Combined chronic dietary exposure to four nephrotoxic metals exceeds tolerable intake levels in the adult population of 10 European countries. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2023; 40:1568-1588. [PMID: 37922338 DOI: 10.1080/19440049.2023.2272716] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 10/12/2023] [Indexed: 11/05/2023]
Abstract
A mixture risk assessment (MRA) for four metals relevant to chronic kidney disease (CKD) was performed. Dietary exposure to cadmium or lead alone exceeded the respective reference values in the majority of the 10 European countries included in our study. When the dietary exposure to those metals and inorganic mercury and inorganic arsenic was combined following a classical or personalised modified reference point index (mRPI) approach, not only high exposure (95th percentile) estimates but also the mean exceeded the tolerable intake of the mixture in all countries studied. Cadmium and lead contributed most to the combined exposure, followed by inorganic arsenic and inorganic mercury. The use of conversion factors for inorganic arsenic and inorganic mercury from total arsenic and total mercury concentration data was a source of uncertainty. Other uncertainties were related to the use of different principles to derive reference points. Yet, MRA at the target organ level, as performed in our study, could be used as a way to efficiently prioritise assessment groups for higher-tier MRA. Since the combined exposure to the four metals exceeded the tolerable intake, we recommend a refined MRA based on a common, specific nephrotoxic effect and relative potency factors (RPFs) based on a similar effect size.
Collapse
Affiliation(s)
- R Corinne Sprong
- Department of Chemical Food Safety, RIVM, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Annick D van den Brand
- Centre for Health Protection, RIVM, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Gerda van Donkersgoed
- Department of Chemical Food Safety, RIVM, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Urska Blaznik
- National Institute of Public Health, Environmental Health Centre, Ljubljana, Slovenia
| | | | - Amélie Crépet
- Risk Assessment Department, Methodology and Studies Unit, ANSES, French Agency for Food, Environmental and Occupational Health and Safety, Maisons-Alfort, France
| | | | - Bodil Hamborg Jensen
- Technical University of Denmark, National Food Institute, Research group for Chemical Risk Assessment and GMO, Lyngby, Denmark
| | - Angelo Morretto
- Department of Cardiac Thoracic Vascular and Public Health Sciences, University of Padova and Occupational Health Unit, Padova University Hospital, Padova, Italy
| | | | - Jiri Ruprich
- National Institute of Public Health in Prague, Centre for Health, Nutrition and Food, Brno, Czech Republic
| | - Darja Sokolić
- HAPIH, Croatian Agency for Agriculture and Food, Osijek, Croatia
| | - Jacob D van Klaveren
- Department of Chemical Food Safety, RIVM, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Mirjam Luijten
- Centre for Health Protection, RIVM, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Marcel J B Mengelers
- Department of Chemical Food Safety, RIVM, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| |
Collapse
|
7
|
Moon S, Lee J, Yu JM, Choi H, Choi S, Park J, Choi K, Kim E, Kim H, Kim MJ, Park YJ. Association between environmental cadmium exposure and increased mortality in the U.S. National Health and Nutrition Examination Survey (1999-2018). JOURNAL OF EXPOSURE SCIENCE & ENVIRONMENTAL EPIDEMIOLOGY 2023; 33:874-882. [PMID: 37161056 DOI: 10.1038/s41370-023-00556-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/15/2022] [Revised: 04/22/2023] [Accepted: 04/24/2023] [Indexed: 05/11/2023]
Abstract
BACKGROUND Cadmium (Cd) is toxic to human health and increases overall mortality. In this study, we investigated the association between Cd exposure and all-cause, cardiovascular (CVD), and cancer mortality in the general population and the mediating effect of smoking on these association. METHODS We used data from U.S. National Health and Nutrition Examination Survey for 1999-2018. To evaluate the hazard ratio (HR) for mortality, a multiple Cox regression analysis was conducted by adjusting for age, sex, race/ethnicity, body mass index, smoking, alcohol, hypertension, diabetes, hyperlipidemia, and history of CVD and cancer. A causal mediation analysis was performed to estimate the effects of smoking. RESULTS Among the 31,637 subjects, 5452 (12.3%) died. Blood Cd concentrations were significantly associated with all-cause (HR 1.473, 95% confidence interval [CI] 1.403-1.546, p < 0.001), CVD (HR 1.445, 95% CI 1.344-1.554, p < 0.001), and cancer (HR 1.496, 95% CI 1.406-1.592, p < 0.001) mortality. Urinary Cd concentrations were also significantly associated with them. Using feature selection via machine learning, the importance of Cd in all-cause and cancer mortality was second only to age. The association between Cd concentrations and all-cause mortality was significant in both ever-smokers and never-smokers. The mediating effect of smoking was estimated at 32%, whereas a large proportion (68%) remained a direct effect of Cd. In a subgroup analysis of subjects with cancer history, blood Cd concentrations were significantly associated with cancer-related deaths in those with a history of breast, gastrointestinal, and skin cancers. CONCLUSION High Cd exposure is an important risk factor for all-cause, CVD, and cancer mortality among the general population. Cd exposure increased the risk of death even in never-smokers, and its effects unrelated to smoking were substantial, suggesting the importance of regulating other sources of Cd exposure such as food and water. IMPACT STATEMENT Using national large-scale data, we found that low-level environmental exposure to cadmium significantly increased the risk of all-cause, cardiovascular, and cancer mortality in the general population even after adjusting for several risk factors. Although smoking is a major source of cadmium exposure, cadmium was nevertheless significantly associated with all-cause mortality in never-smokers, and the mediating effect of smoking on this association was only 32%. Hence, other sources of cadmium exposure such as food and water may be important.
Collapse
Affiliation(s)
- Shinje Moon
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea
| | - Junghoon Lee
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea
| | - Jae Myung Yu
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea
| | - Hoonsung Choi
- Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea
| | - Sohyeon Choi
- Department of Environmental Health Sciences, Soonchunhyang University, Asan, Republic of Korea
| | - Jeongim Park
- Department of Environmental Health Sciences, Soonchunhyang University, Asan, Republic of Korea
| | - Kyungho Choi
- Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea
- Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea
| | - Ejin Kim
- Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea
- Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea
| | - Ho Kim
- Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea
- Institute of Health and Environment, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea
| | - Min Joo Kim
- Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Republic of Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
| | - Young Joo Park
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
- Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea
| |
Collapse
|
8
|
Piasek M, Škrgatić L, Sulimanec A, Orct T, Sekovanić A, Kovačić J, Katić A, Branović Čakanić K, Pizent A, Brajenović N, Jurič A, Brčić Karačonji I, Kljaković-Gašpić Z, Tariba Lovaković B, Lazarus M, Stasenko S, Miškulin I, Jurasović J. Effects of Maternal Cigarette Smoking on Trace Element Levels and Steroidogenesis in the Maternal-Placental-Fetal Unit. TOXICS 2023; 11:714. [PMID: 37624219 PMCID: PMC10459679 DOI: 10.3390/toxics11080714] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 08/16/2023] [Accepted: 08/17/2023] [Indexed: 08/26/2023]
Abstract
This study evaluates the interaction of toxic elements cadmium (Cd) and lead (Pb) due to exposure from cigarette smoking, essential elements, and steroidogenesis in the maternal-placental-fetal unit. In a cohort of 155 healthy, postpartum women with vaginal term deliveries in clinical hospitals in Zagreb, Croatia, samples of maternal blood/serum and urine, placental tissue, and umbilical cord blood/serum were collected at childbirth. The biomarkers determined were concentrations of Cd, Pb, iron (Fe), zinc (Zn), copper (Cu), and selenium (Se), and steroid hormones progesterone and estradiol in maternal and umbilical cord blood and the placenta. Three study groups were designated based on self-reported data on cigarette smoking habits and confirmed by urine cotinine levels: never smokers (n = 71), former smokers (n = 48), and active smokers (n = 36). Metal(loid)s, steroid hormones, urine cotinine, and creatinine levels were analyzed by ICP-MS, ELISA, GC-MS, and spectrophotometry. Cigarette smoking during pregnancy was associated with increased Cd levels in maternal, placental, and fetal compartments, Pb in the placenta, and with decreased Fe in the placenta. In active smokers, decreased progesterone and estradiol concentrations in cord blood serum were found, while sex steroid hormones did not change in either maternal serum or placenta. This study provides further evidence regarding toxic and essential metal(loid) interactions during prenatal life, and new data on sex steroid disruption in cord serum related to cigarette smoking. The results indicate that umbilical cord sex steroid levels may be a putative early marker of developmental origins of the future burden of disease related to harmful prenatal exposure to cigarette smoke.
Collapse
Affiliation(s)
- Martina Piasek
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Lana Škrgatić
- University Hospital Centre, Petrova 13, 10000 Zagreb, Croatia; (L.Š.); (I.M.)
- School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia
| | - Antonija Sulimanec
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Tatjana Orct
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Ankica Sekovanić
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Jelena Kovačić
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Anja Katić
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | | | - Alica Pizent
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Nataša Brajenović
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Andreja Jurič
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Irena Brčić Karačonji
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Zorana Kljaković-Gašpić
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Blanka Tariba Lovaković
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Maja Lazarus
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| | - Sandra Stasenko
- Merkur University Hospital, Zajčeva ulica 19, 10000 Zagreb, Croatia;
| | - Iva Miškulin
- University Hospital Centre, Petrova 13, 10000 Zagreb, Croatia; (L.Š.); (I.M.)
| | - Jasna Jurasović
- Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000 Zagreb, Croatia; (M.P.); (A.S.); (T.O.); (A.S.); (J.K.); (A.K.); (A.P.); (N.B.); (A.J.); (I.B.K.); (Z.K.-G.); (B.T.L.); (M.L.)
| |
Collapse
|
9
|
Loh MM, Schmidt P, Christopher de Vries Y, Vogel N, Kolossa-Gehring M, Vlaanderen J, Lebret E, Luijten M. Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept. TOXICS 2023; 11:toxics11050408. [PMID: 37235224 DOI: 10.3390/toxics11050408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/19/2023] [Revised: 03/25/2023] [Accepted: 03/29/2023] [Indexed: 05/28/2023]
Abstract
Chemical mixture risk assessment has, in the past, primarily focused on exposures quantified in the external environment. Assessing health risks using human biomonitoring (HBM) data provides information on the internal concentration, from which a dose can be derived, of chemicals to which human populations are exposed. This study describes a proof of concept for conducting mixture risk assessment with HBM data, using the population-representative German Environmental Survey (GerES) V as a case study. We first attempted to identify groups of correlated biomarkers (also known as 'communities', reflecting co-occurrence patterns of chemicals) using a network analysis approach (n = 515 individuals) on 51 chemical substances in urine. The underlying question is whether the combined body burden of multiple chemicals is of potential health concern. If so, subsequent questions are which chemicals and which co-occurrence patterns are driving the potential health risks. To address this, a biomonitoring hazard index was developed by summing over hazard quotients, where each biomarker concentration was weighted (divided) by the associated HBM health-based guidance value (HBM-HBGV, HBM value or equivalent). Altogether, for 17 out of the 51 substances, health-based guidance values were available. If the hazard index was higher than 1, then the community was considered of potential health concern and should be evaluated further. Overall, seven communities were identified in the GerES V data. Of the five mixture communities where a hazard index was calculated, the highest hazard community contained N-Acetyl-S-(2-carbamoyl-ethyl)cysteine (AAMA), but this was the only biomarker for which a guidance value was available. Of the other four communities, one included the phthalate metabolites mono-isobutyl phthalate (MiBP) and mono-n-butyl phthalate (MnBP) with high hazard quotients, which led to hazard indices that exceed the value of one in 5.8% of the participants included in the GerES V study. This biological index method can put forward communities of co-occurrence patterns of chemicals on a population level that need further assessment in toxicology or health effects studies. Future mixture risk assessment using HBM data will benefit from additional HBM health-based guidance values based on population studies. Additionally, accounting for different biomonitoring matrices would provide a wider range of exposures. Future hazard index analyses could also take a common mode of action approach, rather than the more agnostic and non-specific approach we have taken in this proof of concept.
Collapse
Affiliation(s)
- Miranda M Loh
- Institute of Occupational Medicine-IOM, Edinburgh EH14 4AP, UK
| | | | | | - Nina Vogel
- German Environment Agency (UBA), 14195 Berlin, Germany
| | | | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands
| | - Erik Lebret
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3584 CM Utrecht, The Netherlands
- Center for Sustainability, Environment and Health, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands
| | - Mirjam Luijten
- Center for Health Protection, National Institute for Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands
| |
Collapse
|
10
|
Lombaert N, Gilles M, Verougstraete V. Cadmium Monitoring at the Workplace: Effectiveness of a Combination of Air- and Biomonitoring. TOXICS 2023; 11:354. [PMID: 37112581 PMCID: PMC10147057 DOI: 10.3390/toxics11040354] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/09/2023] [Revised: 03/30/2023] [Accepted: 04/06/2023] [Indexed: 06/19/2023]
Abstract
Inhalation exposure to cadmium at the workplace has been associated with an increased risk of lung cancer and non-cancer respiratory effects. To ensure levels of cadmium remain below effect levels, air quality is monitored and regulations specifying an air limit value are implemented. The EU Carcinogens and Mutagens Directive of 2019 recommended values for the inhalable fraction and the respirable fraction but the latter only for a transitional period. Cadmium exposure has also been associated with systemic effects, following its storage in the kidneys and due to its long half-life. The accumulation of cadmium occurs via different exposure routes and from different sources, including workplace dust and fumes, food, and smoking. Biomonitoring (in blood, urine) has been identified as the most appropriate method to follow up cumulative exposure and total cadmium body burden, as it conveniently reflects intakes by all routes. However, it is not systematically implemented. This paper has a double objective: first, proposing a possible limit value for the respirable fraction, using an approach integrating epidemiological data. Secondly, demonstrating that the implementation of both air and biological limit values is key to protecting workers' health in occupational settings. The paper summarizes the current knowledge on cadmium health effects and how biomarkers reflect those. It presents an approach to derive a respirable value, using recent human data, and describes how the combination of air monitoring and biomonitoring is applied by the EU industry to protect the workforce. While a respirable fraction value helps protect workers against local respiratory adverse health effects, air monitoring alone is not sufficient to protect workers against systemic effects of cadmium. Therefore, complementary biomonitoring and the implementation of a biological limit value is recommended.
Collapse
Affiliation(s)
- Noömi Lombaert
- International Cadmium Association, 1150 Brussels, Belgium
- International Zinc Association, Reach Cadmium Consortium, 1150 Brussels, Belgium
| | - Mik Gilles
- International Cadmium Association, 1150 Brussels, Belgium
| | | |
Collapse
|
11
|
Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021). Int J Hyg Environ Health 2023; 249:114119. [PMID: 36773580 DOI: 10.1016/j.ijheh.2023.114119] [Citation(s) in RCA: 30] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 12/19/2022] [Accepted: 01/24/2023] [Indexed: 02/11/2023]
Abstract
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures.
Collapse
|
12
|
Santonen T, Mahiout S, Alvito P, Apel P, Bessems J, Bil W, Borges T, Bose-O'Reilly S, Buekers J, Cañas Portilla AI, Calvo AC, de Alba González M, Domínguez-Morueco N, López ME, Falnoga I, Gerofke A, Caballero MDCG, Horvat M, Huuskonen P, Kadikis N, Kolossa-Gehring M, Lange R, Louro H, Martins C, Meslin M, Niemann L, Díaz SP, Plichta V, Porras SP, Rousselle C, Scholten B, Silva MJ, Šlejkovec Z, Tratnik JS, Joksić AŠ, Tarazona JV, Uhl M, Van Nieuwenhuyse A, Viegas S, Vinggaard AM, Woutersen M, Schoeters G. How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU. Int J Hyg Environ Health 2023; 249:114139. [PMID: 36870229 DOI: 10.1016/j.ijheh.2023.114139] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 02/13/2023] [Accepted: 02/14/2023] [Indexed: 03/06/2023]
Abstract
One of the aims of the European Human Biomonitoring Initiative, HBM4EU, was to provide examples of and good practices for the effective use of human biomonitoring (HBM) data in human health risk assessment (RA). The need for such information is pressing, as previous research has indicated that regulatory risk assessors generally lack knowledge and experience of the use of HBM data in RA. By recognising this gap in expertise, as well as the added value of incorporating HBM data into RA, this paper aims to support the integration of HBM into regulatory RA. Based on the work of the HBM4EU, we provide examples of different approaches to including HBM in RA and in estimations of the environmental burden of disease (EBoD), the benefits and pitfalls involved, information on the important methodological aspects to consider, and recommendations on how to overcome obstacles. The examples are derived from RAs or EBoD estimations made under the HBM4EU for the following HBM4EU priority substances: acrylamide, o-toluidine of the aniline family, aprotic solvents, arsenic, bisphenols, cadmium, diisocyanates, flame retardants, hexavalent chromium [Cr(VI)], lead, mercury, mixture of per-/poly-fluorinated compounds, mixture of pesticides, mixture of phthalates, mycotoxins, polycyclic aromatic hydrocarbons (PAHs), and the UV-filter benzophenone-3. Although the RA and EBoD work presented here is not intended to have direct regulatory implications, the results can be useful for raising awareness of possibly needed policy actions, as newly generated HBM data from HBM4EU on the current exposure of the EU population has been used in many RAs and EBoD estimations.
Collapse
Affiliation(s)
| | | | - Paula Alvito
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; Centre for Environmental and Marine Studies (CESAM), University of Aveiro, 3810-193 Aveiro, Portugal
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Jos Bessems
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | - Wieneke Bil
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Teresa Borges
- General-Directorate of Health, Ministry of Health, 1049-005, Lisbon, Portugal
| | - Stephan Bose-O'Reilly
- Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - Private University for Health Sciences, Medical Informations und Technology, Hall i.T., Austria
| | - Jurgen Buekers
- VITO-Flemish Institute for Technological Research, Mol, Belgium
| | | | - Argelia Castaño Calvo
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | | | - Marta Esteban López
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | | | - Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | | | | | | | | | | - Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Henriqueta Louro
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | - Carla Martins
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | - Matthieu Meslin
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Lars Niemann
- German Federal Institute for Risk Assessment, Berlin, Germany
| | - Susana Pedraza Díaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain
| | - Veronika Plichta
- Austrian Agency for Health and Food Safety, Department Risk Assessment, Spargelfeldstraße 191, 1220, Vienna, Austria
| | | | - Christophe Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety, Anses, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, France
| | - Bernice Scholten
- Research Group Risk Analysis for Products in Development, The Netherlands Organisation for Applied Scientific research (TNO), Utrecht, the Netherlands
| | - Maria João Silva
- National Institute of Health Dr. Ricardo Jorge, 1649-016, Lisbon, Portugal; ToxOmics-Centre for Toxicogenomics and Human Health, NOVA Medical School, Universidade NOVA de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056, Lisboa, Portugal
| | | | | | | | - Jose V Tarazona
- National Centre for Environmental Health, Instituto de Salud Carlos III, Madrid, Spain; European Food Safety Authority (EFSA), Parma, Italy
| | - Maria Uhl
- Environment Agency Austria, Spittelauer Lände 5, 1090, Vienna, Austria
| | | | - Susana Viegas
- NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, 1600-560, Lisbon, Portugal; Comprehensive Health Research Center (CHRC), NOVA University Lisbon, 1600-560, Lisbon, Portugal
| | | | - Marjolijn Woutersen
- National Institute for Public Health and the Environment, Bilthoven, the Netherlands
| | - Greet Schoeters
- VITO-Flemish Institute for Technological Research, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences, Antwerp, Belgium
| |
Collapse
|
13
|
Lobo Vicente J, Ganzleben C, Gasol R, Marnane I, Gilles L, Buekers J, Bessems J, Colles A, Gerofke A, David M, Barouki R, Uhl M, Sepai O, Loots I, Crabbé A, Coertjens D, Kolossa-Gehring M, Schoeters G. HBM4EU results support the Chemicals' Strategy for Sustainability and the Zero-Pollution Action Plan. Int J Hyg Environ Health 2023; 248:114111. [PMID: 36706581 DOI: 10.1016/j.ijheh.2023.114111] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Revised: 12/12/2022] [Accepted: 01/05/2023] [Indexed: 01/27/2023]
Abstract
One of the major goals of the European Human Biomonitoring Initiative (HBM4EU) was to bridge the gap between science and policy by consulting both policy makers and national scientists and generating evidence of the actual exposure of residents to chemicals and whether that exposure would be suggest a potential health risk. Residents' perspectives on chemical exposure and risk were also investigated. HBM4EU's research was designed to answer specific short-term and long-term policy questions at national and European levels, and for its results to directly support regulatory action on chemicals. A strategy was established to prioritise chemicals for analysis in human matrices, with a total of 18 substances/substance groups chosen to be investigated throughout the five-and a -half-year project. HBM4EU produced new evidence of human exposure levels, developed reference values for exposure, investigated determinants of exposure and derived health-based guidance values for those substances. In addition, HBM4EU promoted the use of human biomonitoring data in chemical risk assessment and developed innovative tools and methods linking chemicals to possible health impacts, such as effect biomarkers. Furthermore, HBM4EU advanced understand of effects from combined exposures and methods to identify emerging chemicals. With the aim of supporting policy implementation, science-to-policy workshops were organised, providing opportunities for joint reflection and dialogue on research results. I, and indicators were developed to assess temporal and spatial patterns in the exposure of European population. A sustainable human biomonitoring monitoring framework, producing comparable quality assured data would allow: the evaluation of time trends; the exploration of spatial trends: the evaluation of the influence of socio-economic conditions on chemical exposure. Therefore, such a framework should be included in the European Chemicals' Strategy for Sustainability and the data would support the Zero Pollution Action Plan.
Collapse
Affiliation(s)
- Joana Lobo Vicente
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark.
| | - Catherine Ganzleben
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Roser Gasol
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Ian Marnane
- European Environment Agency (EEA), Kongens Nytorv 6, 1050 Copenhagen K, Denmark
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Jurgen Buekers
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Jos Bessems
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Ann Colles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - Antje Gerofke
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Madlen David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | | | - Maria Uhl
- Environment Agency, Spittelauer Lände 5, Vienna, 1090, Austria
| | - Ovnair Sepai
- United Kingdom Health Security Agency, Harwell Science Park, Chilton, OX11 0RQ, UK
| | - Ilse Loots
- University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - Ann Crabbé
- University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - Dries Coertjens
- University of Antwerp, Department of Sociology (CRESC and IMDO), Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; University of Antwerp, Dept of Biomedical Sciences and Toxicological Centre, Universiteitsplein 1, 2610, Wilrijk, Belgium
| |
Collapse
|
14
|
Apel P, Lamkarkach F, Lange R, Sissoko F, David M, Rousselle C, Schoeters G, Kolossa-Gehring M. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results. Int J Hyg Environ Health 2023; 248:114097. [PMID: 36577283 DOI: 10.1016/j.ijheh.2022.114097] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2022] [Revised: 12/01/2022] [Accepted: 12/02/2022] [Indexed: 12/27/2022]
Abstract
The European Initiative HBM4EU aimed to further establish human biomonitoring across Europe as an important tool for determining population exposure to chemicals and as part of health-related risk assessments, thus making it applicable for policy advice. Not only should analytical methods and survey design be harmonized and quality assured, but also the evaluation of human biomonitoring data. For the health-related interpretation of the data within HBM4EU, a strategy for deriving health-based human biomonitoring guidance values (HBM-GVs) for both the general population and workers was agreed on. On this basis, HBM-GVs for exposure biomarkers of 1,2-cyclohexane dicarboxylic acid diisononyl ester (DINCH), phthalates (diethyl hexyl phthalate (DEHP), di-n-butyl phthalate (DnBP), diisobutyl phthalate (DiBP), butyl benzyl phthalate (BBzP), and bis-(2-propylheptyl) phthalate (DPHP)), bisphenols A and S, pyrethroids (deltamethrin and cyfluthrin), solvents (1-methyl-2-pyrrolidone (NMP), 1-ethylpyrrolidin-2-one (NEP), N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAC)), the heavy metal cadmium and the mycotoxin deoxynivalenol (DON) were developed and assigned a level of confidence. The approach to HBM-GV derivations, results, and limitations in data interpretation with special focus on the pyrethroids are presented in this paper.
Collapse
Affiliation(s)
- P Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
| | - F Lamkarkach
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France
| | - R Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - F Sissoko
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France
| | - M David
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - C Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France
| | - G Schoeters
- VITO Health, Flemish Institute for Technological Research, 2400, Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, 2610, Antwerp, Belgium
| | - M Kolossa-Gehring
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| |
Collapse
|
15
|
Xiong L, Fan C, Song J, Wan Y, Lin X, Su Z, Qiu J, Wu W, He Z, Wu Y, Yang X. Associations of long-term cadmium exposure with peripheral white blood cell subtype counts and indices in residents of cadmium-polluted areas. CHEMOSPHERE 2022; 308:135946. [PMID: 36007735 DOI: 10.1016/j.chemosphere.2022.135946] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 07/29/2022] [Accepted: 08/01/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Experimental evidence suggests that exposure to cadmium (Cd) could affect immune cells in vivo and in vitro. However, the associations of long-term Cd exposure with white blood cell (WBC) subtype counts and hemogram-derived indices have been rarely investigated. Therefore, we evaluated these relationships in residents of cadmium-polluted areas. METHODS This cross-sectional study included 431 participants aged 45-75 years without occupational exposure histories from Cd-contaminated areas of southern China. We detected WBC, neutrophil, lymphocyte, and monocyte counts using routine blood tests and calculated neutrophil-lymphocyte ratio (NLR), systemic inflammation response index (SIRI), and lymphocyte-monocyte ratio (LMR). Urinary Cd (U-Cd) was measured with inductively coupled plasma mass spectrometry and adjusted for creatinine. To evaluate the associations of U-Cd with peripheral WBC subtype counts and indices, we performed multivariate linear regression, logistic regression and subgroup analyses using U-Cd categorized into quartiles. RESULTS In models adjusted for all potential confounders, U-Cd was negatively associated with WBC, neutrophil, and monocyte counts in Q2, compared with Q1 of U-Cd (p < 0.05). A similar relationship was observed between U-Cd and NLR and SIRI, whereas the corresponding association for LMR was positive (p < 0.05). In subgroup analyses, U-Cd was negatively associated with neutrophil count, except for never smokers, after full adjustment. CONCLUSIONS U-Cd was negatively associated with WBC count, neutrophil count, monocyte count, NLR, and SIRI, and positively associated with LMR. Therefore, neutrophil count could be a potential indicator of long-term Cd exposure-associated immunosuppressive effect.
Collapse
Affiliation(s)
- Lili Xiong
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Cuihua Fan
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Jia Song
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Yu Wan
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Xiuqin Lin
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Zujian Su
- Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangdong, 510000, China
| | - Jianmin Qiu
- The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - WeiLiang Wu
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Zhini He
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China
| | - Yongning Wu
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China; NHC Key Laboratory of Food Safety Risk Assessment, Food Safety Research Unit (2019RU014) of Chinese Academy of Medical Science, China National Center for Food Safety Risk Assessment, Beijing, 100021, China.
| | - Xingfen Yang
- Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, Guangdong-Hongkong-Macao Joint Laboratory for Contaminants Exposure and Health, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510000, China.
| |
Collapse
|
16
|
Rooney JPK, Michalke B, Geoghegan G, Heverin M, Bose-O'Reilly S, Hardiman O, Rakete S. Urine concentrations of selected trace metals in a cohort of Irish adults. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2022; 29:75356-75364. [PMID: 35655008 PMCID: PMC9553804 DOI: 10.1007/s11356-022-21169-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Accepted: 05/25/2022] [Indexed: 05/27/2023]
Abstract
Human biomonitoring studies are of increasing importance in regulatory toxicology; however, there is a paucity of human biomonitoring data for the Irish population. In this study, we provide new data for urinary biomarker concentrations of aluminium, arsenic, cadmium, chromium, copper, mercury, manganese, lead and selenium. One hundred urine samples, collected between 2011 and 2014 from healthy participants of the EuroMOTOR project, were randomly selected. Metal concentrations were measured via ICPMS. Descriptive statistics for each of the metals stratified by gender were performed. There were 58 male and 42 female participants and metals were detectable for all samples. Geometric mean urinary concentrations for each metal in males were as follows: aluminium 8.5 μg/L, arsenic 8.1 μg/L, cadmium 0.3 μg/L, chromium 0.5 μg/L, copper 5.1 μg/L, mercury 0.4 μg/L, manganese 0.3 μg/L, lead 1.3 μg/L and selenium 10.8 μg/L; and in females: aluminium 8.5 μg/L, arsenic 10.2 μg/L, cadmium 0.4 μg/L, chromium 0.6 μg/L, copper 5.6 μg/L, mercury 0.3 μg/L, manganese 0.2 μg/L, lead 1.6 μg/L and selenium 13.7 μg/L. We observed higher geometric mean concentrations in women for arsenic, cadmium, chromium, copper, lead and selenium, with equal geometric mean concentrations for aluminium and manganese, leaving only mercury with lower geometric mean concentrations in women. Aluminium, cadmium, chromium, lead and urinary concentrations of metals were slightly elevated compared to European data, while for arsenic, copper, manganese and selenium, Irish levels were lower. Our findings highlight that there are differences in urinary metal concentrations between European populations.
Collapse
Affiliation(s)
- James P K Rooney
- Institute and Clinic for Occupational-, Social- and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.
- Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
| | - Bernhard Michalke
- Research Unit Analytical BioGeoChemistry, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany
| | - Gráinne Geoghegan
- Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
| | - Mark Heverin
- Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
| | - Stephan Bose-O'Reilly
- Institute and Clinic for Occupational-, Social- and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
- Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Medical Informatics and Technology, Health Services Research and Health Technology Assessment, UMIT - Private University for Health Sciences, Hall in Tirol, Austria
| | - Orla Hardiman
- Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland
- Department of Neurology, Beaumont Hospital, Glasnevin, Dublin, Ireland
| | - Stefan Rakete
- Institute and Clinic for Occupational-, Social- and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany
| |
Collapse
|
17
|
Cadmium exposure in adults across Europe: Results from the HBM4EU Aligned Studies survey 2014–2020. Int J Hyg Environ Health 2022; 246:114050. [DOI: 10.1016/j.ijheh.2022.114050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 09/30/2022] [Accepted: 10/05/2022] [Indexed: 11/06/2022]
|
18
|
[Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2022; 65:936-939. [PMID: 35997778 PMCID: PMC9436871 DOI: 10.1007/s00103-022-03578-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/01/2022] [Indexed: 11/24/2022]
Abstract
Beim Human-Biomonitoring wird die innere Schadstoffbelastung des Menschen aus verschiedenen Quellen wie Nahrung, Alltagsgegenständen oder Atemluft erfasst, indem z. B. Blut und Urin analysiert werden. Um das Human-Biomonitoring in Europa zu fördern und zu koordinieren, wurde 2017 das Projekt „Human-Biomonitoring für Europa“ (HBM4EU) begonnen, an dem sich 30 Länder, die Europäische Umweltagentur und die Europäische Kommission beteiligt haben. Im Juni 2022 wurde das Projekt abgeschlossen. Vergleichbare und zuverlässige Belastungsdaten konnten für eine breite Palette von Umweltchemikalien erfasst und einheitlich bewertet werden. Weitere wichtige Erfolge der Initiative waren die Etablierung eines Kontrollprogramms zur Qualitätssicherung, ein Konzept zur Vereinheitlichung zukünftiger HBM-Studien, eine gemeinsame Strategie zur Ableitung von gesundheitsbezogenen Beurteilungswerten (HBM Guidance Values – HBM-GVs) und die Einrichtung nationaler Gremien. Die gewonnenen Belastungsdaten sind über die Informationsplattform für die Überwachung von Chemikalien (IPCHEM) und das EU HBM-Dashboard zugänglich. Publikationen sind über die HBM4EU-Onlinebibliothek frei verfügbar. Insgesamt zeigen die Ergebnisse, dass die Belastungen der EU-Bevölkerung für viele Chemikalien wie etwa Phthalate und perfluorierte Alkylsubstanzen (PFAS) zu hoch sind und weiterhin Handlungsbedarf seitens der Politik besteht. Das im Projekt HBM4EU generierte Wissen kann die politischen Entscheidungsträger:innen bei der Verbesserung der Chemikalien‑, Umwelt- und Gesundheitspolitik unterstützen.
Collapse
|
19
|
Tarazona JV, Cattaneo I, Niemann L, Pedraza-Diaz S, González-Caballero MC, de Alba-Gonzalez M, Cañas A, Dominguez-Morueco N, Esteban-López M, Castaño A, Borges T, Katsonouri A, Makris KC, Ottenbros I, Mol H, De Decker A, Morrens B, Berman T, Barnett-Itzhaki Z, Probst-Hensch N, Fuhrimann S, Tratnik JS, Horvat M, Rambaud L, Riou M, Schoeters G, Govarts E, Kolossa-Gehring M, Weber T, Apel P, Namorado S, Santonen T. A Tiered Approach for Assessing Individual and Combined Risk of Pyrethroids Using Human Biomonitoring Data. TOXICS 2022; 10:451. [PMID: 36006130 PMCID: PMC9416723 DOI: 10.3390/toxics10080451] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Revised: 07/29/2022] [Accepted: 08/01/2022] [Indexed: 12/04/2022]
Abstract
Pyrethroids are a major insecticide class, suitable for biomonitoring in humans. Due to similarities in structure and metabolic pathways, urinary metabolites are common to various active substances. A tiered approach is proposed for risk assessment. Tier I was a conservative screening for overall pyrethroid exposure, based on phenoxybenzoic acid metabolites. Subsequently, probabilistic approaches and more specific metabolites were used for refining the risk estimates. Exposure was based on 95th percentiles from HBM4EU aligned studies (2014-2021) covering children in Belgium, Cyprus, France, Israel, Slovenia, and The Netherlands and adults in France, Germany, Israel, and Switzerland. In all children populations, the 95th percentiles for 3-phenoxybenzoic acid (3-PBA) exceeded the screening value. The probabilistic refinement quantified the risk level of the most exposed population (Belgium) at 2% or between 1-0.1% depending on the assumptions. In the substance specific assessments, the 95th percentiles of urinary concentrations in the aligned studies were well below the respective human biomonitoring guidance values (HBM-GVs). Both information sets were combined for refining the combined risk. Overall, the HBM data suggest a low health concern, at population level, related to pyrethroid exposure for the populations covered by the studies, even though a potential risk for highly exposed children cannot be completely excluded. The proposed tiered approach, including a screening step and several refinement options, seems to be a promising tool of scientific and regulatory value in future.
Collapse
Affiliation(s)
- Jose V. Tarazona
- European Food Safety Authority (EFSA), 43126 Parma, Italy
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | - Irene Cattaneo
- European Food Safety Authority (EFSA), 43126 Parma, Italy
| | - Lars Niemann
- Department of Safety of Pesticides, German Federal Institute for Risk Assessment, 10589 Berlin, Germany
| | - Susana Pedraza-Diaz
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | | | | | - Ana Cañas
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | | | - Marta Esteban-López
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | - Argelia Castaño
- National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Madrid, Spain
| | - Teresa Borges
- General-Directorate of Health, Ministry of Health, 1049-005 Lisbon, Portugal
| | | | - Konstantinos C. Makris
- Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, Limassol 3036, Cyprus
| | - Ilse Ottenbros
- National Institute for Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, 3721 Bilthoven, The Netherlands
| | - Hans Mol
- Wageningen Food Safety Research (WFSR), 6700 Wageningen, The Netherlands
| | | | - Bert Morrens
- Department of Sociology, University of Antwerp, 2020 Antwerpen, Belgium
| | | | - Zohar Barnett-Itzhaki
- Ruppin Research Group in Environmental and Social Sustainability, Ruppin Academic Center, Emek Hefer 4025000, Israel
| | - Nicole Probst-Hensch
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland
| | - Samuel Fuhrimann
- Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland
| | - Janja Snoj Tratnik
- Jozef Stefan Institute, Department of Environmental Sciences, 1000 Jubljana, Slovenia
| | - Milena Horvat
- Jozef Stefan Institute, Department of Environmental Sciences, 1000 Jubljana, Slovenia
| | - Loic Rambaud
- Department of Environmental and Occupational Health, Santé Publique France, 12 rue du Val d’Osne, Saint-Maurice, CEDEX, 94415 Paris, France
| | - Margaux Riou
- Department of Environmental and Occupational Health, Santé Publique France, 12 rue du Val d’Osne, Saint-Maurice, CEDEX, 94415 Paris, France
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2020 Mol, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2020 Mol, Belgium
| | | | - Till Weber
- German Environment Agency (UBA), 14195 Berlin, Germany
| | - Petra Apel
- German Environment Agency (UBA), 14195 Berlin, Germany
| | - Sonia Namorado
- Department of Epidemiology, National Institute of Health Dr. Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisbon, Portugal
| | - Tiina Santonen
- Finnish Institute of Occupational Health, Työterveyslaitos, P.O. Box 40, 00032 Helsinki, Finland
| |
Collapse
|
20
|
Hanser O, Melczer M, Martin Remy A, Ndaw S. Occupational exposure to metals among battery recyclers in France: Biomonitoring and external dose measurements. WASTE MANAGEMENT (NEW YORK, N.Y.) 2022; 150:122-130. [PMID: 35810728 DOI: 10.1016/j.wasman.2022.06.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Revised: 06/03/2022] [Accepted: 06/30/2022] [Indexed: 06/15/2023]
Abstract
In battery-recycling facilities, exposure to trace elements may occur through inhalation of contaminated dust or vapor emanating from the treatment processes. Exposure of battery-recycling workers to lead has been quite well covered in the literature. In contrast, we lack data on exposure to other elements contained in batteries. The aim of this study was to characterize the exposure of French battery recyclers to multiple elements using biomonitoring and airborne measurements. Eighty-six workers participated in the study. Inhalable metal concentrations were determined for personal airborne samples, and total exposure was determined from pre-shift and post-shift urine samples collected during the working week. In both types of sample, a total of 33 trace elements were measured using inductively coupled plasma mass spectrometry. Results showed battery recyclers to be mostly exposed to Cd, Co, Cr, Li, Mn, Ni, and Pb. Administrative and sorting workers were exposed at lower levels than maintenance, treatment, and dismantling workers. Cd, Co, Li, Mn, and Ni were detected at high levels in air samples, especially near the treatment facilities, with airborne cadmium levels of up to 79.4 µg/m3. Urinary sample analysis indicated exposure to Cd and Co, with levels measured at up to 27.6 and 3.34 µg/g of creatinine, respectively. Concentrations were compared to data reported for e-waste recycling companies. The data presented provide valuable information on exposure to trace elements for workers involved in battery-recycling. They also highlight the need to improve both collective and individual protective measures, which were not sufficient in the participating companies.
Collapse
Affiliation(s)
- Ogier Hanser
- Toxicology and Biomonitoring Department, INRS-French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases, 54500 Vandoeuvre-lès-Nancy, France.
| | - Mathieu Melczer
- Toxicology and Biomonitoring Department, INRS-French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases, 54500 Vandoeuvre-lès-Nancy, France
| | - Aurélie Martin Remy
- Toxicology and Biomonitoring Department, INRS-French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases, 54500 Vandoeuvre-lès-Nancy, France
| | - Sophie Ndaw
- Toxicology and Biomonitoring Department, INRS-French National Research and Safety Institute for the Prevention of Occupational Accidents and Diseases, 54500 Vandoeuvre-lès-Nancy, France
| |
Collapse
|
21
|
Chatterjee M, Kortenkamp A. Cadmium exposures and deteriorations of cognitive abilities: estimation of a reference dose for mixture risk assessments based on a systematic review and confidence rating. Environ Health 2022; 21:69. [PMID: 35836177 PMCID: PMC9281031 DOI: 10.1186/s12940-022-00881-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 06/24/2022] [Indexed: 05/24/2023]
Abstract
To support a mixture risk assessment with a focus on developmental neurotoxicity we evaluated the strength of evidence for associations of cadmium exposures with declines in IQ by conducting a systematic review and confidence rating. We searched peer-reviewed studies published in English between 2012 and July 2021 and identified 15 eligible studies (11 prospective cohort studies, and 4 cross-sectional studies). Of the 10 studies that observed associations of cadmium exposure with child IQ declines, two achieved an overall "High (H)" confidence rating, five a "Medium to High (M/H)", one a "Medium (M)" and two a "Low (L)" confidence rating. Five studies did not detect significant associations between cadmium exposure and reduced cognitive ability; of these, two received a "High (H)" confidence rating, two an overall rating of "Medium to High (M/H)" and one a "Medium (M)" rating. The null findings reported by the "High (H)" and Medium to High (M/H)" studies could partly be explained by low exposures to cadmium or confounding with high levels of lead. By using a one-compartment toxicokinetic model in a reverse dosimetry approach, we estimated that a daily intake of 0.2 μg/kg body weight/day corresponds to urinary cadmium levels no longer associated with cognitive declines observed in a "High (H)"-confidence study. This estimate is 1.8-fold lower than the current health-based guidance value (HBGV) for kidney toxicity of 0.36 μg/kg bodyweight/day established by the European Food Safety Authority (EFSA). Our value does not have the normative character associated with health-based guidance values and is intended only as a reasonable estimate for the purpose of mixture risk assessments. However, with cadmium exposures in Europe between 0.28 (middle bound) and up to 0.52 μg/kg bodyweight/day (95th percentile), our review suggests that pregnant women and children are poorly protected against neurodevelopmental effects. This warrants a revision of the current HBGV.
Collapse
Affiliation(s)
- Mousumi Chatterjee
- College of Health, Medicine and Life Sciences, Brunel University London, Centre for Pollution Research and Policy Kingston Lane, Uxbridge, UB8 3PH UK
| | - Andreas Kortenkamp
- College of Health, Medicine and Life Sciences, Brunel University London, Centre for Pollution Research and Policy Kingston Lane, Uxbridge, UB8 3PH UK
| |
Collapse
|
22
|
Gilles L, Govarts E, Rodriguez Martin L, Andersson AM, Appenzeller BMR, Barbone F, Castaño A, Coertjens D, Den Hond E, Dzhedzheia V, Eržen I, López ME, Fábelová L, Fillol C, Franken C, Frederiksen H, Gabriel C, Haug LS, Horvat M, Halldórsson TI, Janasik B, Holcer NJ, Kakucs R, Karakitsios S, Katsonouri A, Klánová J, Kold-Jensen T, Kolossa-Gehring M, Konstantinou C, Koponen J, Lignell S, Lindroos AK, Makris KC, Mazej D, Morrens B, Murínová ĽP, Namorado S, Pedraza-Diaz S, Peisker J, Probst-Hensch N, Rambaud L, Rosolen V, Rucic E, Rüther M, Sarigiannis D, Tratnik JS, Standaert A, Stewart L, Szigeti T, Thomsen C, Tolonen H, Eiríksdóttir Á, Van Nieuwenhuyse A, Verheyen VJ, Vlaanderen J, Vogel N, Wasowicz W, Weber T, Zock JP, Sepai O, Schoeters G. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:6787. [PMID: 35682369 PMCID: PMC9180444 DOI: 10.3390/ijerph19116787] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Accepted: 05/24/2022] [Indexed: 11/17/2022]
Abstract
Human biomonitoring has become a pivotal tool for supporting chemicals' policies. It provides information on real-life human exposures and is increasingly used to prioritize chemicals of health concern and to evaluate the success of chemical policies. Europe has launched the ambitious REACH program in 2007 to improve the protection of human health and the environment. In October 2020 the EU commission published its new chemicals strategy for sustainability towards a toxic-free environment. The European Parliament called upon the commission to collect human biomonitoring data to support chemical's risk assessment and risk management. This manuscript describes the organization of the first HBM4EU-aligned studies that obtain comparable human biomonitoring (HBM) data of European citizens to monitor their internal exposure to environmental chemicals. The HBM4EU-aligned studies build on existing HBM capacity in Europe by aligning national or regional HBM studies. The HBM4EU-aligned studies focus on three age groups: children, teenagers, and adults. The participants are recruited between 2014 and 2021 in 11 to 12 primary sampling units that are geographically distributed across Europe. Urine samples are collected in all age groups, and blood samples are collected in children and teenagers. Auxiliary information on socio-demographics, lifestyle, health status, environment, and diet is collected using questionnaires. In total, biological samples from 3137 children aged 6-12 years are collected for the analysis of biomarkers for phthalates, HEXAMOLL® DINCH, and flame retardants. Samples from 2950 teenagers aged 12-18 years are collected for the analysis of biomarkers for phthalates, Hexamoll® DINCH, and per- and polyfluoroalkyl substances (PFASs), and samples from 3522 adults aged 20-39 years are collected for the analysis of cadmium, bisphenols, and metabolites of polyaromatic hydrocarbons (PAHs). The children's group consists of 50.4% boys and 49.5% girls, of which 44.1% live in cities, 29.0% live in towns/suburbs, and 26.8% live in rural areas. The teenagers' group includes 50.6% girls and 49.4% boys, with 37.7% of residents in cities, 31.2% in towns/suburbs, and 30.2% in rural areas. The adult group consists of 52.6% women and 47.4% men, 71.9% live in cities, 14.2% in towns/suburbs, and only 13.4% live in rural areas. The study population approaches the characteristics of the general European population based on age-matched EUROSTAT EU-28, 2017 data; however, individuals who obtained no to lower educational level (ISCED 0-2) are underrepresented. The data on internal human exposure to priority chemicals from this unique cohort will provide a baseline for Europe's strategy towards a non-toxic environment and challenges and recommendations to improve the sampling frame for future EU-wide HBM surveys are discussed.
Collapse
Affiliation(s)
- Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (E.G.); (L.R.M.); (A.S.); (V.J.V.); (G.S.)
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (E.G.); (L.R.M.); (A.S.); (V.J.V.); (G.S.)
| | - Laura Rodriguez Martin
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (E.G.); (L.R.M.); (A.S.); (V.J.V.); (G.S.)
| | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark; (A.-M.A.); (H.F.)
| | | | - Fabio Barbone
- Department of Medicine—DAME, University of Udine, Via Colugna 50, 33100 Udine, Italy;
| | - Argelia Castaño
- Centro Nacional de Sanidad Ambiental (CNSA), Instituto de Salud Carlos III, 28029 Madrid, Spain; (A.C.); (M.E.L.); (S.P.-D.)
| | - Dries Coertjens
- Department of Sociology, University of Antwerp, 2020 Antwerp, Belgium; (D.C.); (B.M.)
| | - Elly Den Hond
- Provincial Institute for Hygiene, 2000 Antwerp, Belgium; (E.D.H.); (C.F.)
| | - Vazha Dzhedzheia
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (V.D.); (C.G.); (S.K.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
| | - Ivan Eržen
- National Institute of Public Health, 1000 Ljubljana, Slovenia;
| | - Marta Esteban López
- Centro Nacional de Sanidad Ambiental (CNSA), Instituto de Salud Carlos III, 28029 Madrid, Spain; (A.C.); (M.E.L.); (S.P.-D.)
| | - Lucia Fábelová
- Faculty of Public Health, Slovak Medical University, 833 03 Bratislava, Slovakia; (L.F.); (Ľ.P.M.)
| | - Clémence Fillol
- Santé Publique France, Environmental and Occupational Health Division, 94415 Saint-Maurice, France; (C.F.); (L.R.)
| | - Carmen Franken
- Provincial Institute for Hygiene, 2000 Antwerp, Belgium; (E.D.H.); (C.F.)
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark; (A.-M.A.); (H.F.)
| | - Catherine Gabriel
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (V.D.); (C.G.); (S.K.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
| | - Line Småstuen Haug
- Division for Climate and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, Norway; (L.S.H.); (C.T.)
| | - Milena Horvat
- Department of Environmental Sciences, Jožef Stefan Institute, 1000 Ljubljana, Slovenia; (M.H.); (D.M.); (J.S.T.)
| | | | - Beata Janasik
- Nofer Institute of Occupational Medicine (NIOM), 91-348 Lodz, Poland; (B.J.); (W.W.)
| | - Nataša Janev Holcer
- Croatian Institute of Public Health, Division for Environmental Health, 1000 Zagreb, Croatia;
- Department of Social Medicine and Epidemiology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia
| | - Réka Kakucs
- National Public Health Center, 1097 Budapest, Hungary; (R.K.); (T.S.)
| | - Spyros Karakitsios
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (V.D.); (C.G.); (S.K.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
| | - Andromachi Katsonouri
- Cyprus State General Laboratory, Ministry of Health , P.O. Box 28648, 2081 Nicosia, Cyprus;
| | - Jana Klánová
- Masaryk University Research Centre for Toxic Compounds in the Environment (RECETOX), 625 00 Bohunice, Czech Republic;
| | - Tina Kold-Jensen
- Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, 5000 Odense, Denmark;
| | - Marike Kolossa-Gehring
- German Environment Agency (UBA), 14195 Berlin, Germany; (M.K.-G.); (J.P.); (E.R.); (M.R.); (N.V.); (T.W.)
| | - Corina Konstantinou
- Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, 3603 Limassol, Cyprus; (C.K.); (K.C.M.)
| | - Jani Koponen
- Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), P.O. Box 30, 00271 Helsinki, Finland;
| | - Sanna Lignell
- Swedish Food Agency, 751 26 Uppsala, Sweden; (S.L.); (A.K.L.)
| | | | - Konstantinos C. Makris
- Cyprus International Institute for Environmental and Public Health, Cyprus University of Technology, 3603 Limassol, Cyprus; (C.K.); (K.C.M.)
| | - Darja Mazej
- Department of Environmental Sciences, Jožef Stefan Institute, 1000 Ljubljana, Slovenia; (M.H.); (D.M.); (J.S.T.)
| | - Bert Morrens
- Department of Sociology, University of Antwerp, 2020 Antwerp, Belgium; (D.C.); (B.M.)
| | | | - Sónia Namorado
- National Institute of Health, 1649-016 Lisbon, Portugal;
- Public Health Research Centre, NOVA National School of Public Health, Universidade NOVA de Lisboa, 1099-085 Lisbon, Portugal
| | - Susana Pedraza-Diaz
- Centro Nacional de Sanidad Ambiental (CNSA), Instituto de Salud Carlos III, 28029 Madrid, Spain; (A.C.); (M.E.L.); (S.P.-D.)
| | - Jasmin Peisker
- German Environment Agency (UBA), 14195 Berlin, Germany; (M.K.-G.); (J.P.); (E.R.); (M.R.); (N.V.); (T.W.)
| | - Nicole Probst-Hensch
- Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland;
- Department of Clinical Research, University of Basel, 4051 Basel, Switzerland
| | - Loïc Rambaud
- Santé Publique France, Environmental and Occupational Health Division, 94415 Saint-Maurice, France; (C.F.); (L.R.)
| | - Valentina Rosolen
- Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, 34137 Trieste, Italy;
| | - Enrico Rucic
- German Environment Agency (UBA), 14195 Berlin, Germany; (M.K.-G.); (J.P.); (E.R.); (M.R.); (N.V.); (T.W.)
| | - Maria Rüther
- German Environment Agency (UBA), 14195 Berlin, Germany; (M.K.-G.); (J.P.); (E.R.); (M.R.); (N.V.); (T.W.)
| | - Dimosthenis Sarigiannis
- Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (V.D.); (C.G.); (S.K.); (D.S.)
- HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001 Thessaloniki, Greece
- Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto—Piazza della Vittoria 15, 27100 Pavia, Italy
| | - Janja Snoj Tratnik
- Department of Environmental Sciences, Jožef Stefan Institute, 1000 Ljubljana, Slovenia; (M.H.); (D.M.); (J.S.T.)
| | - Arnout Standaert
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (E.G.); (L.R.M.); (A.S.); (V.J.V.); (G.S.)
| | | | - Tamás Szigeti
- National Public Health Center, 1097 Budapest, Hungary; (R.K.); (T.S.)
| | - Cathrine Thomsen
- Division for Climate and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, Norway; (L.S.H.); (C.T.)
| | - Hanna Tolonen
- Department of Health Security, Finnish Institute for Health and Welfare (THL), P.O. Box 95, 70701 Kuopio, Finland;
| | - Ása Eiríksdóttir
- Faculty of Food Science and Nutrition, University of Iceland, 102 Reykjavik, Iceland; (T.I.H.); (Á.E.)
| | - An Van Nieuwenhuyse
- Department Health Protection, Laboratoire National de Santé, 3555 Dudelange, Luxembourg;
| | - Veerle J. Verheyen
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (E.G.); (L.R.M.); (A.S.); (V.J.V.); (G.S.)
- Department of Biomedical Sciences, University of Antwerp, 2020 Antwerp, Belgium
| | - Jelle Vlaanderen
- Institute for Risk Assessment Sciences (IRAS), Utrecht University, 3508 TC Utrecht, The Netherlands;
| | - Nina Vogel
- German Environment Agency (UBA), 14195 Berlin, Germany; (M.K.-G.); (J.P.); (E.R.); (M.R.); (N.V.); (T.W.)
| | - Wojciech Wasowicz
- Nofer Institute of Occupational Medicine (NIOM), 91-348 Lodz, Poland; (B.J.); (W.W.)
| | - Till Weber
- German Environment Agency (UBA), 14195 Berlin, Germany; (M.K.-G.); (J.P.); (E.R.); (M.R.); (N.V.); (T.W.)
| | - Jan-Paul Zock
- National Institute for Public Health and the Environment (RIVM), 3721 MA Bilthoven, The Netherlands;
| | - Ovnair Sepai
- UK Health Security Agency, London SE1 8UG, UK; (L.S.); (O.S.)
| | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium; (E.G.); (L.R.M.); (A.S.); (V.J.V.); (G.S.)
- Department of Biomedical Sciences, University of Antwerp, 2020 Antwerp, Belgium
| |
Collapse
|
23
|
Human Biomonitoring Initiative (HBM4EU): Human Biomonitoring Guidance Values Derived for Dimethylformamide. TOXICS 2022; 10:toxics10060298. [PMID: 35736906 PMCID: PMC9230076 DOI: 10.3390/toxics10060298] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/22/2022] [Revised: 05/13/2022] [Accepted: 05/26/2022] [Indexed: 02/04/2023]
Abstract
Within the European Joint Program on Human Biomonitoring HBM4EU, human biomonitoring guidance values (HBM-GVs) for the general population (HBM-GVGenPop) or for occupationally exposed adults (HBM-GVWorker) are derived for prioritized substances including dimethylformamide (DMF). The methodology to derive these values that was agreed upon within the HBM4EU project was applied. A large database on DMF exposure from studies conducted at workplaces provided dose–response relationships between biomarker concentrations and health effects. The hepatotoxicity of DMF has been identified as having the most sensitive effect, with increased liver enzyme concentrations serving as biomarkers of the effect. Out of the available biomarkers of DMF exposure studied in this paper, the following were selected to derive HBM-GVWorker: total N-methylformamide (tNMF) (sum of N-hydroxymethyl-N-methylformamide and NMF) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) in urine. The proposed HBM-GVWorker is 10 mg·L−1 or 10 mg·g−1 creatinine for both biomarkers. Due to their different half-lives, tNMF (representative of the exposure of the day) and AMCC (representative of the preceding days’ exposure) are complementary for the biological monitoring of workers exposed to DMF. The levels of confidence for these HBM-GVWorker are set to “high” for tNMF and “medium-low” for AMCC. Therefore, further investigations are required for the consolidation of the health-based HBM-GV for AMCC in urine.
Collapse
|
24
|
Socianu S, Bopp SK, Govarts E, Gilles L, Buekers J, Kolossa-Gehring M, Backhaus T, Franco A. Chemical Mixtures in the EU Population: Composition and Potential Risks. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph19106121. [PMID: 35627658 PMCID: PMC9141134 DOI: 10.3390/ijerph19106121] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Revised: 05/09/2022] [Accepted: 05/13/2022] [Indexed: 02/04/2023]
Abstract
Regulating chemical mixtures is a complex scientific and policy task. The aim of this study was to investigate typical mixtures and their potential risks based on internal exposure levels in the European population. Based on human biomonitoring (HBM) data made available via the HBM4EU project, we derived generic mixtures representative of a median (P50) and a worst-case scenario (P95) for adults and children. We performed a mixture risk assessment based on HBM concentrations, health-based guidance values (HBGVs) as internal thresholds of concern, and the conservative assumption of concentration addition applied across different toxicological endpoints. Maximum cumulative ratios (MCRs) were calculated to characterize the mixture risk. The mixtures comprise 136 biomarkers for adults and 84 for children, although concentration levels could be quantified only for a fraction of these. Due to limited availability of HBGVs, the mixture risk was assessed for a subset of 20 substance-biomarker pairs for adults and 17 for children. The mixture hazard index ranged from 2.8 (P50, children) to 9.2 (P95, adults). Six to seven substances contributed to over 95% of the total risk. MCR values ranged between 2.6 and 5.5, which is in a similar range as in previous studies based on human external exposures assessments. The limited coverage of substances included in the calculations and the application of a hazard index across toxicological endpoints argue for caution in the interpretation of the results. Nonetheless the analyses of MCR and MAFceiling can help inform a possible mixture assessment factor (MAF) applicable to single substance risk assessment to account for exposure to unintentional mixtures.
Collapse
Affiliation(s)
- Sebastian Socianu
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy; (S.S.); (A.F.)
| | - Stephanie K. Bopp
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy; (S.S.); (A.F.)
- Correspondence: ; Tel.: +39-0332-789950
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (E.G.); (L.G.); (J.B.)
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (E.G.); (L.G.); (J.B.)
| | - Jurgen Buekers
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400 Mol, Belgium; (E.G.); (L.G.); (J.B.)
| | | | - Thomas Backhaus
- Department of Biological and Environmental Sciences, University of Gothenburg, Carl Skottsbergs Gata 22B, 41319 Gothenburg, Sweden;
| | - Antonio Franco
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy; (S.S.); (A.F.)
| |
Collapse
|
25
|
Schoeters G, Verheyen VJ, Colles A, Remy S, Martin LR, Govarts E, Nelen V, Den Hond E, De Decker A, Franken C, Loots I, Coertjens D, Morrens B, Bastiaensen M, Gys C, Malarvannan G, Covaci A, Nawrot T, De Henauw S, Bellemans M, Leermakers M, Van Larebeke N, Baeyens W, Jacobs G, Voorspoels S, Nielsen F, Bruckers L. Internal exposure of Flemish teenagers to environmental pollutants: Results of the Flemish Environment and Health Study 2016-2020 (FLEHS IV). Int J Hyg Environ Health 2022; 242:113972. [PMID: 35453051 DOI: 10.1016/j.ijheh.2022.113972] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2022] [Revised: 04/07/2022] [Accepted: 04/09/2022] [Indexed: 12/12/2022]
Abstract
The Flemish Environment and Health Study (FLEHS) collects information on internal exposure to a broad range of environmental chemicals in the general population in Flanders, the Northern region of Belgium. The aim is to establish biomonitoring exposure distributions for the general population in support of public health and environmental policy, environmental risk assessment and risk management decisions. In 2017-2018, urine and blood samples were collected from 428 teenagers by a stratified clustered two stage randomized design. Samples were analyzed for a broad range of biomarkers related to exposure to chlorinated and newer pesticides, brominated and organophosphate flame retardants (BFR/OPFR), polychlorinated biphenyls (PCBs), bisphenols, phthalates and alternative plasticizers, per-and polyfluoroalkyl substances (PFAS), polycyclic aromatic hydrocarbons (PAHs), benzene, metals and trace elements. The geometric mean levels and percentiles of the distribution were estimated for each biomarker, for the whole study population and following stratification for sex, the household educational attainment and the residence area's urbanicity. Geometric means of biomarkers of lead, dichlorodiphenyltrichloroethane (DDT), PCBs, PAHs, regulated phthalates and bisphenol A (BPA) were lower than in the previous FLEHS cycles. Most biomarker levels were below health-based guidance values (HB-GVs). However, HB-GVs of urinary arsenic, blood lead, blood cadmium, sum of serum perfluorooctane sulfonate (PFOS) and perfluoro-1-hexanesulfonate (PFHxS) and the urinary pyrethroid metabolite (3-PBA) were exceeded in respectively 25%, 12%, 39.5%, 10% and 22% of the teenagers. These results suggest that the levels of exposure in the Flemish population to some environmental chemicals might be of concern. At the same time, we noticed that biomarkers for BPA substitutes, metabolites of OPFRs, an expanded list of PFAS, glyphosate and its metabolite could be measured in substantial proportions of participants. Interpretation of these levels in a health-risk context remains uncertain as HB-GVs are lacking. Household educational attainment and residential urbanicity were significant exposure determinants for many biomarkers and could influence specific biomarker levels up to 70% as shown by multiple regression analysis. The research consortium also took care of the broader external communication of results with participants, policy makers, professional groups and civil society organizations. Our study demonstrated that teenagers are exposed to a wide range of chemicals, it demonstrates the success of public policies to reduce exposure but also points to concern and further priorities and needs for follow up.
Collapse
Affiliation(s)
- G Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium.
| | - V J Verheyen
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - A Colles
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - S Remy
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - L Rodriguez Martin
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - E Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - V Nelen
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - E Den Hond
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - A De Decker
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - C Franken
- Provincial Institute of Hygiene, Kronenburgstraat 45, 2000, Antwerp, Belgium
| | - I Loots
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - D Coertjens
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - B Morrens
- Department of Sociology, Faculty of Social Sciences, University of Antwerp, Sint-Jacobstraat 2, 2000, Antwerp, Belgium
| | - M Bastiaensen
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - C Gys
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - G Malarvannan
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - A Covaci
- Toxicological Centre, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Belgium
| | - T Nawrot
- Centre for Environmental Sciences, Hasselt University, Agoralaan building D, 3590, Diepenbeek, Belgium
| | - S De Henauw
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
| | - M Bellemans
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium
| | - M Leermakers
- Analytical, Environmental and Geo- Chemistry, Vrije Universiteit Brussel, Brussels, Belgium
| | - N Van Larebeke
- Analytical, Environmental and Geo- Chemistry, Vrije Universiteit Brussel, Brussels, Belgium
| | - W Baeyens
- Analytical, Environmental and Geo- Chemistry, Vrije Universiteit Brussel, Brussels, Belgium
| | - G Jacobs
- VITO GOAL, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - S Voorspoels
- VITO GOAL, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium
| | - F Nielsen
- Institute of Public Health, Department of Environmental Medicine, University of Southern Denmark, Odense, Denmark
| | - L Bruckers
- BioStat, Data Science Institute, Hasselt University, Martelarenlaan 42, 3500, Hasselt, Belgium
| |
Collapse
|
26
|
Markiewicz-Górka I, Chowaniec M, Martynowicz H, Wojakowska A, Jaremków A, Mazur G, Wiland P, Pawlas K, Poręba R, Gać P. Cadmium Body Burden and Inflammatory Arthritis: A Pilot Study in Patients from Lower Silesia, Poland. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:3099. [PMID: 35270791 PMCID: PMC8910441 DOI: 10.3390/ijerph19053099] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Revised: 02/24/2022] [Accepted: 03/04/2022] [Indexed: 12/04/2022]
Abstract
The purpose of this study was to determine the relationship between cadmium exposure and the likelihood of developing or exacerbating symptoms of inflammatory arthritis (IA). The study included 51 IA patients and 46 control subjects. Demographic and lifestyle data were collected. Haematological and biochemical parameters and blood cadmium levels (Cd-B) were determined. Cd-B correlated positively with age, smoking, living in a high-traffic area, and serum levels of inflammatory markers and negatively with mean corpuscular haemoglobin concentration (MCHC). The binary logistic regression model implied that high Cd-B (≥0.65 μg/L) is linked with an increased risk of IA in the studied population (odds ratio: 4.4). High levels of DNA oxidative damage marker (8-hydroxy-2'-deoxyguanosine) (≥7.66 ng/mL) and cyclooxygenase-2 (≥22.9 ng/mL) and frequent consumption of offal was also associated with increased risk of IA. High Cd-B was related to increased risk of disease symptoms onset in the group of IA patients, decreased the level of interleukin 10, and positively correlated with the disease activity. Increased Cd-B is associated with intensified inflammatory processes and decreased haemoglobin levels; in IA patients with decreased anti-inflammatory interleukin 10. These changes partly explain why cadmium exposure and a high cadmium body burden may raise the risk of IA and of disease symptoms exacerbation.
Collapse
Affiliation(s)
- Iwona Markiewicz-Górka
- Division of Environmental Health and Occupational Medicine, Department of Population Health, Wroclaw Medical University, 7 Mikulicza-Radeckiego St., 50-345 Wroclaw, Poland; (M.C.); (A.J.); (K.P.); (P.G.)
| | - Małgorzata Chowaniec
- Division of Environmental Health and Occupational Medicine, Department of Population Health, Wroclaw Medical University, 7 Mikulicza-Radeckiego St., 50-345 Wroclaw, Poland; (M.C.); (A.J.); (K.P.); (P.G.)
- Department of Rheumatology and Internal Medicine, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland;
| | - Helena Martynowicz
- Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland; (H.M.); (A.W.); (G.M.); (R.P.)
| | - Anna Wojakowska
- Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland; (H.M.); (A.W.); (G.M.); (R.P.)
| | - Aleksandra Jaremków
- Division of Environmental Health and Occupational Medicine, Department of Population Health, Wroclaw Medical University, 7 Mikulicza-Radeckiego St., 50-345 Wroclaw, Poland; (M.C.); (A.J.); (K.P.); (P.G.)
| | - Grzegorz Mazur
- Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland; (H.M.); (A.W.); (G.M.); (R.P.)
| | - Piotr Wiland
- Department of Rheumatology and Internal Medicine, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland;
| | - Krystyna Pawlas
- Division of Environmental Health and Occupational Medicine, Department of Population Health, Wroclaw Medical University, 7 Mikulicza-Radeckiego St., 50-345 Wroclaw, Poland; (M.C.); (A.J.); (K.P.); (P.G.)
| | - Rafał Poręba
- Department of Internal and Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland; (H.M.); (A.W.); (G.M.); (R.P.)
| | - Paweł Gać
- Division of Environmental Health and Occupational Medicine, Department of Population Health, Wroclaw Medical University, 7 Mikulicza-Radeckiego St., 50-345 Wroclaw, Poland; (M.C.); (A.J.); (K.P.); (P.G.)
| |
Collapse
|
27
|
The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP). Int J Hyg Environ Health 2021; 238:113856. [PMID: 34619432 PMCID: PMC8573589 DOI: 10.1016/j.ijheh.2021.113856] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 10/01/2021] [Accepted: 10/02/2021] [Indexed: 11/20/2022]
Abstract
Toxicologically and/or epidemiologically derived guidance values referring to the internal exposure of humans are a prerequisite for an easy to use health-based interpretation of human biomonitoring (HBM) results. The European Joint Programme HBM4EU derives such values, named human biomonitoring guidance values (HBM-GVs), for priority substances which could be of regulatory relevance for policy makers and have been identified by experts of the participating countries, ministries, agencies and stakeholders at EU and national level. NMP and NEP are such substances for which unresolved policy relevant issues should be clarified by targeted research. Since widespread exposure of the general population in Germany to NMP and NEP was shown for the age groups 3–17 years and 20–29 years, further investigations on exposure to NMP and NEP in other European countries are warranted. The HBM-GVs derived for both solvents focus on developmental toxicity as decisive endpoint. They amount for the sum of the two specific urinary NMP metabolites 5-HNMP and 2-HMSI and likewise of the two specific urinary NEP metabolites 5-HNEP and 2-HESI to 10 mg/L for children and 15 mg/L for adolescents/adults. The values were determined following a consultation process on the value proposals within HBM4EU. A health-based risk assessment was performed using the newly derived HBM-GVGenPop and exposure data from two recent studies from Germany. The risk assessment revealed that even when considering the combined exposure to both substances by applying the Hazard Index approach, the measured concentrations are below the HBM-GVGenPop in all cases investigated (i.e., children, adolescents and young adults). HBM-GVs are a prerequisite for an easy to use health-based risk assessment of human biomonitoring results. For NMP and NEP metabolites in urine, respectively, HBM-GVs were set for children and adolescents/adults. First HBM exposure data indicate widespread exposure of German children, adolescents and young adults to NMP and NEP. The Hazard Index approach revealed that even when combined exposure to both solvents is assessed, HBM-GVs are not exceeded.
Collapse
|
28
|
Almerud P, Zamaratskaia G, Lindroos AK, Bjermo H, Andersson EM, Lundh T, Ankarberg EH, Lignell S. Cadmium, total mercury, and lead in blood and associations with diet, sociodemographic factors, and smoking in Swedish adolescents. ENVIRONMENTAL RESEARCH 2021; 197:110991. [PMID: 33705767 DOI: 10.1016/j.envres.2021.110991] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 02/10/2021] [Accepted: 03/03/2021] [Indexed: 06/12/2023]
Abstract
BACKGROUND Despite their vulnerability to the toxic effects of certain metals, biomonitoring data on adolescents are limited. In the present study, we assessed blood concentrations of toxic metals (cadmium [Cd], total mercury [Hg], and lead [Pb] in a national representative sample of Swedish adolescents. We also examined the associations of Cd, total Hg and Pb with habitual intakes of major energy-providing food groups and other possible determinants such as age, sex, household education, Nordic or non-Nordic origin, and smoking. METHODS We analysed blood concentrations of Cd, total Hg, and Pb in a sample of 1099 adolescents from the Riksmaten Adolescents 2016-17 study in three age groups (mean age of 12, 15, and 18 years) using inductively coupled plasma mass spectrometry. The participants completed web-based questionnaires on food consumption frequency, sociodemographic factors and health status. Dietary data from two web-based 24-h dietary recalls were used to estimate the habitual intake of 10 major food groups. RESULTS Almost all participants had detectable concentrations of Cd, total Hg, and Pb in whole blood. The median blood concentrations were 0.12 μg/L for Cd, 0.72 μg/L for total Hg, and 7.1 μg/L for Pb. Higher blood concentrations of Cd were observed in girls than in boys, whereas concentrations of total Hg and Pb were higher in boys. We observed an inverse association between Cd and meat intake. Total Hg concentrations were positively associated with intakes of fish, eggs, meat, and vegetables, and Pb concentrations were inversely associated with intakes of dairy products. Furthermore, smokers had higher concentrations of Cd and Pb. CONCLUSIONS We found that fish was a potentially important source of exposure to total Hg in Swedish adolescents. No other food group was identified to have a strong impact on the blood levels of Cd, total Hg and Pb. Thirteen per cent of the adolescents had blood Pb concentrations above 12 μg/L, the reference point used in the risk assessment of Pb by the European Food Safety Authority (EFSA).
Collapse
Affiliation(s)
- Pernilla Almerud
- Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Galia Zamaratskaia
- Department of Risk and Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Anna Karin Lindroos
- Department of Risk and Benefit Assessment, Swedish Food Agency, Uppsala, Sweden; Department of Internal Medicine and Clinical Nutrition, The Sahlgrenska Academy, University of Gothenburg, Sweden
| | - Helena Bjermo
- Department of Risk and Benefit Assessment, Swedish Food Agency, Uppsala, Sweden
| | - Eva M Andersson
- Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
| | - Thomas Lundh
- Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden
| | | | - Sanna Lignell
- Department of Risk and Benefit Assessment, Swedish Food Agency, Uppsala, Sweden.
| |
Collapse
|
29
|
Burden of osteoporosis and costs associated with human biomonitored cadmium exposure in three European countries: France, Spain and Belgium. Int J Hyg Environ Health 2021; 234:113747. [PMID: 33862487 DOI: 10.1016/j.ijheh.2021.113747] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 03/24/2021] [Accepted: 03/24/2021] [Indexed: 11/23/2022]
Abstract
Cadmium (Cd) is a toxic heavy metal widespread in the environment leading to human exposure in particular through diet (when smoking is excluded), as documented by recent human biomonitoring (HBM) surveys. Exposure to Cd at environmental low-exposure levels has been associated with adverse effects such as renal toxicity and more recently bone effects. The implication, even if limited, of Cd in the etiology of osteoporosis can be of high importance at the population level given the significant prevalence of osteoporosis and the ubiquitous and life-long exposure to Cd. Therefore, the osteoporosis cases attributable to Cd exposure was estimated in three European countries (Belgium, France and Spain), based on measured urinary Cd levels from HBM studies conducted in these countries. The targeted population was women over 55 years old, for which risk levels associated with environmental Cd exposure were available. Around 23% of the cases were attributed to Cd exposure. Moreover, in a prospective simulation approach of lifelong urinary Cd concentrations assuming different intakes scenarios, future osteoporosis attributable cases were calculated, based on urinary Cd levels measured in women aged under 55. Between 6 and 34% of the considered populations under 55 years were at risk for osteoporosis. Finally, the costs associated to the burden of osteoporosis-related fractures attributable to Cd for each country targeted in this paper were assessed, standing for a major contributing role of Cd exposure in the overall social costs related to osteoporosis. Absolute costs ranged between 0.12 (low estimate in Belgium) and 2.6 billion Euros (high estimate in France) in women currently over 55 years old and at risk for fractures. Our results support the importance of reducing exposure of the general population to Cd.
Collapse
|
30
|
Lange R, Apel P, Rousselle C, Charles S, Sissoko F, Kolossa-Gehring M, Ougier E. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer. Int J Hyg Environ Health 2021; 234:113722. [PMID: 33711757 DOI: 10.1016/j.ijheh.2021.113722] [Citation(s) in RCA: 34] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 02/17/2021] [Accepted: 02/18/2021] [Indexed: 12/18/2022]
Abstract
Ubiquitous use of plasticizers has led to a widespread internal exposure of the European population. Until today, metabolites are detected in almost every urine sample analysed. This raised the urgent need for a toxicological interpretation of the internal exposure levels. The European Human Biomonitoring Initiative (HBM4EU) contributes substantially to the knowledge on the actual exposure of European citizens to chemicals prioritised within HBM4EU, on their potential impact on health and on the interpretation of these data to improve policy making. On that account, human biomonitoring guidance values (HBM-GVs) are derived for the general population and the occupationally exposed population agreed at HBM4EU consortium level. These values can be used to assess phthalate exposure levels measured in HBM studies in a health risk assessment context. HBM-GVs were derived for five phthalates (DEHP, DnBP, DiBP, BBzP and DPHP) and for the non-phthalate substitute Hexamoll® DINCH. For the adult general population, the HBM-GVs for the specific metabolite(s) of the respective parent compounds in urine are the following: 0.5 mg/L for the sum of 5-oxo-MEHP and 5-OH-MEHP; 0.19 mg/L for MnBP, 0.23 mg/L for MiBP; 3 mg/L for MBzP; 0.5 mg/L for the sum of oxo-MPHP and OH-MPHP and 4.5 mg/L for the sum of OH-MINCH and cx-MINCH. The present paper further specifies HBM-GVs for children and for workers.
Collapse
Affiliation(s)
- Rosa Lange
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.
| | - Petra Apel
- German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany
| | - Christophe Rousselle
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort Cedex, France
| | - Sandrine Charles
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort Cedex, France
| | - Fatoumata Sissoko
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort Cedex, France
| | | | - Eva Ougier
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 14 Rue Pierre et Marie Curie, 94701, Maisons-Alfort Cedex, France
| |
Collapse
|